U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07521475) titled 'Evaluation of the Fully Closed Loop Omnipod(R) System in Type 2 Diabetes' on April 03.
Brief Summary: A multi-center, 26-week randomized controlled trial (RCT) to evaluate the safety and efficacy of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, with the primary endpoint after 15 weeks and secondary analysis at 26 weeks; followed by an extension phase after completion of the 26-week trial where the Intervention group will continue to use Omnipod M and the Control group will crossover to use Omnipod M for 26 weeks
Study Start Date: April 20
Stu...